newsfilter
← Latest News
Business Wire·

Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

-FB-102 Continues to Advance Towards the Clinic and Holds Significant Market Potential Across a Variety of Indications- -Leadership Strengthened with the Appointment of Scott Brun, M.D. to the Board of